Vaccine Therapy in Treating Patients Who Have Undergone a Donor Stem Cell Transplant and Have Cytomegalovirus Infection That Has Not Responded to Therapy
Conditions
Interventions
- BIOLOGICAL: cytomegalovirus pp65-specific cytotoxic T lymphocytes
- GENETIC: polymerase chain reaction
- OTHER: diagnostic laboratory biomarker analysis
- OTHER: flow cytometry
- OTHER: immunologic technique
Sponsor
University of Louisville
Collaborators